Our products

ChemoTech’s Tumour Specific Electroporation™ (TSE) technology is designed to deliver controlled electrical stimulation that increases the uptake of anti-cancer drugs within the treated tumour area while limiting unnecessary damage to surrounding healthy tissue. IQwave™ is ChemoTech’s CE-marked electroporation system based on the TSE technology platform.

IQwave™

The IQwave™ system consists of the TSE unit, a handheld probe and sterile treatment electrodes. The system generates tumour-specific electrical stimulation designed to enhance the local uptake of anti- cancer drugs and support controlled treatment of solid tumours.

TSE is designed to reduce unwanted tissue destruction and preserve surrounding healthy tissue while delivering a controlled electrical field across the treated area.

Usage and benefits of IQwave™

IQwave™ is designed to provide physicians with a flexible electroporation platform for the treatment of selected solid superficial tumours. The adjustable handheld probe supports treatment of different tumour sizes and anatomical locations, including areas that may be difficult to access.

Controlled energy delivery designed to reduce the risk of unwanted ablation and tissue destruction.
Multidimensional electrical-field distribution across the treated area.
A compact system designed for practical use by physicians.
Treatment programmes developed for sensitive anatomical areas, including head, neck and oral tumours.
Potential application in larger tumours and tumours with limited response to established treatments, subject to the applicable clinical evidence and regulatory status.

Our Products

News & Press releses

Get in touch

Are you interested in our product?

Our team is here to help with any questions about our products, patents or anything else you may need help with.